Citation Impact

Citing Papers

Myocardial infarction redefined—A consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction
2000 Standout
Clinical Myocardial Perfusion PET/CT
2007
Relationships Between Authors of Clinical Practice Guidelines and the Pharmaceutical Industry
2002 Standout
Regression of Coronary Artery Disease as a Result of Intensive Lipid-Lowering Therapy in Men with High Levels of Apolipoprotein B
1990 Standout
Effects of the dipyridamole test on left ventricular function in coronary artery disease
1992
Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project
2003 Standout
Exercise Standards for Testing and Training
2013 Standout
Prognostic value of thallium-201 single-photon emission computed tomographic myocardial perfusion imaging according to extent of myocardial defect
1994
Long‐term prognostic value of a normal dipyridamole thallium‐201 perfusion scan
1991
Cardiac calcification in adult hemodialysis patients
2002 Standout
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
A Single Intravenous Infusion of Gamma Globulin as Compared with Four Infusions in the Treatment of Acute Kawasaki Syndrome
1991 Standout
Quantification of myocardial blood flow and flow reserve in children with a history of kawasaki disease and normal coronary arteries using positron emission tomography
1996
Cardiovascular Magnetic Resonance in Myocarditis: A JACC White Paper
2009 Standout
Preoperative Dipyridamole Thallium Imaging and Ambulatory Electrocardiographic Monitoring as a Predictor of Perioperative Cardiac Events and Long-term Outcome
1995
Anesthesiology
1997 Standout
Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients
2002 Standout
MRI detection of myocardial perfusion changes by gadolinium‐DTPA infusion during dipyridamole hyperemia
1989
Adenosine receptors: therapeutic aspects for inflammatory and immune diseases
2008 Standout
Hypertrophic Cardiomyopathy
2002 Standout
The emerging role of cardiovascular magnetic resonance in the evaluation of Kawasaki disease
2013
Coronary flow and resistance reserve in patients with chronic aortic regurgitation, angina pectoris and normal coronary arteries
1988
Prediction of coronary events with electron beam computed tomography
2000
Regional thallium-201 washout and myocardial hypertrophy in hypertrophic cardiomyopathy and its relation to exertional chest pain
1993
Coronary flow reserve as a physiologic measure of stenosis severity
1990
Comparison of 201Tl SPET and treadmill exercise testing in patients with Kawasaki disease
2000
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association
2017 Standout
A Perspective on Standardizing the Predictive Power of Noninvasive Cardiovascular Tests by Likelihood Ratio Computation: 2. Clinical Applications
1999
Myocardial Ischemia in Kawasaki Disease Evaluation by Dipyridamole Stress Thallium-201 (Tl-201) Myocardial Imaging and Exercise Stress Test.
1992
Dipyridamole thallium-201 single-photon emission tomography in aortic stenosis: gender differences
1995
“Microvascular angina” as a cause of chest pain with angiographically normal coronary arteries
1988 Standout
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
2005 Standout
Limited coronary flow reserve after dipyridamole in patients with ergonovine-induced coronary vasoconstriction.
1987
Guidelines for clinical use of cardiac radionuclide imaging report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Committee on Radionuclide Imaging), developed in collaboration with the American Society of Nuclear Cardiology
1995
Prognostic Value of Dipyridamole-Thallium Myocardial Scintigraphy in Patients With Kawasaki Disease
1998
Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss
2005 Standout
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease
2008 Standout
Pharmacological stress testing
1999
Assessment of coronary stenoses by myocardial perfusion imaging during pharmacologic coronary vasodilation. VII. Validation of coronary flow reserve as a single integrated functional measure of stenosis severity reflecting all its geometric dimensions
1986
Detection of coronary artery disease by thallium imaging using a combined intravenous dipyridamole and isometric handgrip test in patients with aortic valve stenosis
1987
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Statement for Health Professionals From the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association
2004 Standout
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: Executive Summary
2008 Standout
Positron-emission tomography
1997 Standout
Measurement of Fractional Flow Reserve to Assess the Functional Severity of Coronary-Artery Stenoses
1996 Standout
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Impact of Psychological Factors on the Pathogenesis of Cardiovascular Disease and Implications for Therapy
1999 Standout
Noninvasive assessment of coronary stenoses with myocardial perfusion imaging during pharmacologic coronary vasodilatation
1979
Positron Tomography and Nuclear Magnetic Resonance Imaging
1982 StandoutScienceNobel
Simultaneous Transmission/Emission Myocardial Perfusion Tomography
1996
Silent myocardial ischemia: II. Prognosis and implications for the clinical assessment of patients with coronary artery disease
1987
Usefulness of a high-dose dipyridamole-echocardiography test for diagnosis of syndrome X
1987
Regional myocardial perfusion assessed with N-13 labeled ammonia and positron emission computerized axial tomography
1979
Long-term Consequences of Kawasaki Disease
1996 Standout
Quantitative computer techniques for analyzing coronary arteriograms
1986
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease
2004 Standout
Heart Rate Variability
1996 Standout
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2008 Standout
Detection of coronary artery stenosis in children with Kawasaki disease. Usefulness of pharmacologic stress 201Tl myocardial tomography.
1989
Coronary Angiography of Kawasaki Disease with the Coronary Vasodilator Dipyridamole: Assessment of Distensibility of Affected Coronary Arterial Wall
1988
Vascular Calcification
2004 Standout
ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina11This document was approved by the American College of Cardiology Board of Trustees in March 1999, the American Heart Association Science Advisory and Coordinating Committee in March 1999, and the American College of Physicians-American Society of Internal Medicine Board of Regents in February 1999.When citing this document, please use the following citation format: Gibbons RJ, Chatterjee K, Daley J, Douglas JS, Fihn SD, Gardin JM, Grunwald MA, Levy D, Lytle BW, O’Rourke RA, Schafer WP, Williams SV. ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina). J Am Coll Cardiol 1999;33:2092–197.This document is available on the World Wide Web sites of the American College of Cardiology (www.acc.org) and the American Heart Association (www.americanheart.org). Reprints of this document are available by calling 1-800-253-4636 or writing the American College of Cardiology, Educational Services, at 9111 Old Georgetown Road, Bethesda, MD 20814-1699. Ask for reprint number 71-0166. To obtain a reprint of the Executive Summary and Recommendations published in the June 1, 1999 issue of Circulation, ask for reprint number 71-0167. To purchase bulk reprints (specify version and reprint number): Up to 999 copies call 1-800-611-6083 (US only) or fax 413-665-2671; 1000 or more copies call 214-706-1466, fax 214-691-6342, or e-mail pubauth@heart.org
1999
Vascular Calcification
2008 Standout
Left ventricular function assessed with echocardiography and myocardial perfusion assessed with scintigraphy under dipyridamole stress in pediatric patients after repair for anomalous origin of the left coronary artery from the pulmonary artery
1993
Cardiac Magnetic Resonance Imaging for Noninvasive Assessment of Cardiovascular Disease During the Follow-Up of Patients With Kawasaki Disease
2011

Works of Robin Westcott being referenced

Noninvasive assessment of coronary stenoses by myocardial imaging during pharmacologic coronary vasodilatation. III. Clinical trial
1978
Noninvasive assessment of coronary stenoses by myocardial imaging during pharmacologic coronary vasodilatation
1978
Rankless by CCL
2026